Total Liabilities (Quarterly) Chart

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 1.384M
March 31, 2026 1.433M
December 31, 2025 1.453M
September 30, 2025 1.013M
June 30, 2025 0.3646M
March 31, 2025 0.8153M
December 31, 2024 0.8339M
September 30, 2024 0.813M
June 30, 2024 0.6919M
March 31, 2024 0.6587M
December 31, 2023 0.705M
September 30, 2023 1.579M
June 30, 2023 1.966M
March 31, 2023 1.596M
December 31, 2022 1.638M
September 30, 2022 1.283M
June 30, 2022 1.029M
March 31, 2022 1.061M
Date Value
December 31, 2021 1.103M
September 30, 2021 1.842M
June 30, 2021 1.454M
March 31, 2021 1.044M
December 31, 2020 0.5971M
September 30, 2020 0.5729M
June 30, 2020 0.5901M
March 31, 2020 0.5233M
December 31, 2019 0.4401M
September 30, 2019 0.0253M
June 30, 2019 0.2394M
March 31, 2019 0.0879M
December 31, 2018 0.349M
September 30, 2018 0.0257M
June 30, 2018
March 31, 2018
December 31, 2017 0.0495M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 896.90M
Corcept Therapeutics, Inc. 182.93M
Veru, Inc. 8.651M
Johnson & Johnson 116.09B
Eli Lilly & Co. 108.40B

Total Liabilities (Quarterly) Related Metrics